UniProtKB/Swiss-Prot P02647 : Variant p.Lys131Met
Apolipoprotein A-I
Gene: APOA1
Feedback ?
Variant information
Variant position:
131
The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:
LB/B
The variants are classified into three categories: LP/P, LB/B and US.LP/P: likely pathogenic or pathogenic. LB/B: likely benign or benign. US: uncertain significance
Residue change:
From Lysine (K) to Methionine (M) at position 131 (K131M, p.Lys131Met).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:
Change from large size and basic (K) to medium size and hydrophobic (M)
The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:
-1
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another: Lowest score: -4 (low probability of substitution).Highest score: 11 (high probability of substitution). More information can be found on the following page
Polymorphism:
Genetic variations in APOA1 can result in APOA1 deficiency and are associated with low levels of HDL cholesterol [MIM:107680 ].
Additional information on the polymorphism described.
Other resources:
Links to websites of interest for the variant.
Sequence information
Variant position:
131
The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:
267
The length of the canonical sequence.
Location on the sequence:
SKDLEEVKAKVQPYLDDFQK
K WQEEMELYRQKVEPLRAELQ
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:
The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human SKDLEEVKAKVQPYLDDFQKK WQEEMELYRQKVEPLRAELQ
Gorilla SKDLEEVKAKVQPYLDDFQKK WQEEMELYRQKVEPLRAELQ
SKDLEEVKQKVQPYLDDFQKK WQEEVELYRQKVAPLGSELR
Rhesus macaque SKDLEEVKAKVQPYLDDFQKK WQEEMELYRQKVEPLRAELH
Chimpanzee SKDLEEVKAKVQPYLDDFQKK WQEEMELYRQKVEPLRAELQ
Mouse NKDLEEVKQKVQPYLDEFQKK WKEDVELYRQKVAPLGAELQ
Rat NKDLENVKQKMQPHLDEFQEK WNEEVEAYRQKLEPLGTELH
Pig SKDLEEVKKKVQPYLDDFQNK WQEEMETYRQKMAPLGAEFR
Bovine HKDLEEVKQKVQPYLDEFQKK WHEEVEIYRQKVAPLGEEFR
Rabbit NKDLQEVRQKVQPYLDEFQKK WQEEVERYRQKVEPLGAELR
Chicken TKDLEEVKEKIRPFLDQFSAK WTEELEQYRQRLTPVAQELK
Zebrafish MTDVEDLRSKLEPHRAELYTA LQKHIDEYREKLEPVFQEYS
Sequence annotation in neighborhood:
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
19 – 267
Proapolipoprotein A-I
Chain
25 – 267
Apolipoprotein A-I
Chain
25 – 266
Truncated apolipoprotein A-I
Repeat
123 – 144
4
Region
68 – 267
10 X approximate tandem repeats
Modified residue
136 – 136
Methionine sulfoxide
Mutagenesis
124 – 124
Y -> F. Abolished chlorination and nitration without preventing inhibition in presence of myeloproxidase; when associated with F-42, F-53, F-139, F-190, F-216 and F-260.
Mutagenesis
139 – 139
Y -> F. Abolished chlorination and nitration without preventing inhibition in presence of myeloproxidase; when associated with F-42, F-53, F-124, F-190, F-216 and F-260.
Literature citations
Structural analysis of human apolipoprotein A-I variants. Amino acid substitutions are nonrandomly distributed throughout the apolipoprotein A-I primary structure.
von Eckardstein A.; Funke H.; Walter M.; Altland K.; Benninghoven A.; Assmann G.;
J. Biol. Chem. 265:8610-8617(1990)
Cited for: VARIANTS GLU-113; MET-131; GLY-163; VAL-171 AND LYS-222;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.